Dicerna Pharmaceuticals, Inc. (DRNA)
Q3 2018 Results Earnings Conference Call
November 05, 2018, 04:30 PM ET
Executives
Paula Schwartz - Investor Relations
Douglas Fambrough - President and CEO
Jack Green - CFO
Ralf Rosskamp - Chief Medical Officer
Analysts
Stephen Willey - Stifel
Jonathan Miller - Evercore
Ed Arce - H.C. Wainwright
Keay Nakae - Chardan
Presentation
Operator
Good day, ladies and gentlemen. And welcome to the Q3 2018 Dicerna Pharmaceuticals Earnings Conference Call. At this time all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be